Bioretec Ltd Press release 18 June 2024 at
9:00 a.m. EEST
TAMPERE, Finland, June 18, 2024 /PRNewswire/ -- Bioretec Ltd, a
pioneer in biodegradable orthopedic implants, has, as of
June 17, 2024, appointed Frank Sarcone as Vice President of Sales for
the United States and a member of
Bioretec's Management Team. In his role, Sarcone reports to the
company's CEO. This strategic addition to Bioretec's leadership
team comes as part of the ongoing commitment to driving growth and
innovation in the medical device technology industry.
Frank Sarcone brings with him a
wealth of experience and a remarkable track record in the medical
device sector. With over 25 years of experience, Sarcone is
recognized for his exceptional leadership, strategic acumen, and
ability to build and mentor high-performing teams. His extensive
background includes founding and leading successful orthopedic
companies and developing national distribution channels that have
significantly boosted sales and market presence.
Sarcone's career highlights
include:
- Founding and self-funding two successful orthopedic
companies.
- Establishing long-lasting partnerships and developing extensive
networks within the medical device industry.
- Serving in several key leadership roles such as CEO of Promotus
LLC and IMS Consulting LLC, where he drove significant revenue
growth and spearheaded major sales initiatives.
- His tenure at Stryker Inc., where he managed large teams and
achieved substantial increases in regional market share and
revenue.
Alan Donze, Bioretec's newly
appointed CEO, expressed his confidence in Sarcone's abilities:
"Frank's profound expertise and dynamic leadership style make him
an invaluable addition to our team. His ability to drive strategic
initiatives and his deep understanding of the medical device market
will be pivotal as we continue to expand our footprint and enhance
our product offerings."
Further enquiries
Tomi Numminen, Chairman of the
Board, tel. +358 40 581 2132
Alan Donze, CEO, tel. +358 40 663 5011
Certified advisor
Nordic Certified Adviser AB, +46 70 551
67 29
Information about Bioretec
Bioretec is a globally operating Finnish medical device company
that continues to pioneer the application of biodegradable
orthopedic implants. The company has built unique competencies in
the biological interface of active implants to enhance bone growth
and accelerate fracture healing after orthopedic surgery. The
products developed and manufactured by Bioretec are used worldwide
in approximately 40 countries.
Bioretec is developing the new RemeOs™ product
line based on a magnesium alloy and hybrid composite,
introducing a new generation of strong biodegradable materials for
enhanced surgical outcomes. The RemeOs™ implants are absorbed and
replaced by bone, which eliminates the need for removal surgery
while facilitating fracture healing. The combination has the
potential to make titanium implants redundant and help clinics
reach their Value-Based Healthcare targets while focusing
on value for patients through efficient healthcare. The first
RemeOs™ product market authorization has been received in the U.S.
in March 2023, and in Europe, the CE-mark is expected to be received
during the second quarter of 2024. Bioretec is positioning itself
to enter the addressable USD 7
billion global orthopedic trauma market and become a game
changer in surgical bone fracture treatment.
Better healing - Better life. www.bioretec.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/bioretec/r/bioretec-appoints-frank-sarcone-as-vice-president-of-sales-for-the-us-and-a-member-of-the-management,c4002569
View original
content:https://www.prnewswire.com/news-releases/bioretec-appoints-frank-sarcone-as-vice-president-of-sales-for-the-us-and-a-member-of-the-management-team-302175179.html
SOURCE Bioretec